Education
An April 2021 study published in Psychopharamacology put the anti-anxiety effects of CBD to the test.
In a March 2021 study published in the Journal of Studies on Alcohol and Drugs, researchers examined the relationship between daily cannabis consumption and ADHD symptoms.
An April 2021 study published in the European Journal of Pharmacology delved into how cannabinoid receptors relate to pain management, specifically in the muscles, shed new light on the relationship between the human body's endogenous cannabinoid system (ECS) and muscular pain.
Researchers examined the potential of phytocannabinoids as part of a combination treatment targeting a rare and aggressive form of brain cancer known as glioblastoma multiforme (GBM) in a March 2021 review of existing scientific studies published in the International Journal of Phytotherapy and Phytopharmacology. The review concluded that phytocannabinoids indeed possess anti-cancer properties and were able to arrest or reduce tumor growth rates in both mice and humans.
Researchers studied the effects of a terpene-based formulation, with and without the addition of CBD, against Human Coronavirus strain 229E.
On PubMed.gov, a database maintained by the National Center for Biotechnology Information, there are nearly 25,000 studies referencing cannabis.
Researchers examined a potential link between the ECS and Autism Spectrum Disorder in an article published in the Molecular Diversity Preservation International's publication.
Cannabidiol (CBD) is a household name for its many purported benefits. One of the most striking, however, is its neuroprotective potential – researchers are beginning to unravel the mystery behind how CBD can prevent and forestall neurodegenerative conditions.
An April 2021 review of these studies published in Pharmacology Research & Perspectives determined that Cannabis sativa varieties of the plant are especially effective for anti-microbial purposes.
